Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03769103
Brief Title: Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC

First Submitted : December 3, 2018
First Submitted that Met QC Criteria : December 6, 2018
First Posted : December 7, 2018

Last Update Submitted that Met QC Criteria : February 1, 2021
Last Update Posted : February 2, 2021